<?xml version="1.0"?>
<law>
  <structure>
    <unit label="article" identifier="ghg" order_by="ghg" level="1">Health - General</unit>
  </structure>
  <section_number>ghg-24-806</section_number>
  <catch_line>The Baltimore City Health Department shall include in its Program operating procedures measures to c...</catch_line>
  <order_by>806</order_by>
  <text>
    <section prefix="(a)">The Baltimore City Health Department shall include in its Program operating procedures measures to collect the following data:<section prefix="(1)">The number of participants served by the Program;</section><section prefix="(2)">The length of time a participant is served by the Program;</section><section prefix="(3)">Demographic profiles of participants served by the Program that include:<section prefix="(i)">Age;</section><section prefix="(ii)">Sex;</section><section prefix="(iii)">Race;</section><section prefix="(iv)">Occupation;</section><section prefix="(v)">Zip code of residence;</section><section prefix="(vi)">Types of drugs used;</section><section prefix="(vii)">Length of drug use; and</section><section prefix="(viii)">Frequency of injection;</section></section><section prefix="(4)">The number of hypodermic needles and syringes exchanged;</section><section prefix="(5)">The number of participants entering drug counseling and treatment; and</section><section prefix="(6)">The number of referrals made by the Program for drug counseling and treatment.</section></section>
    <section prefix="(b)">With the advice and approval of the oversight committee, the Baltimore City Health Department shall develop and implement a plan for Program evaluation that shall include the following issues:<section prefix="(1)">The prevalence of HIV among Program participants;</section><section prefix="(2)">Changes in the level of drug use among Program participants;</section><section prefix="(3)">Changes in the level of needle-sharing among Program participants;</section><section prefix="(4)">Changes in the use of condoms among Program participants;</section><section prefix="(5)">The status of treatment and recovery for Program participants who entered drug treatment programs;</section><section prefix="(6)">The impact of the Program on risk behaviors for the transmission of the HIV infection, the hepatitis B virus, and other life-threatening blood-borne diseases among injecting drug users;</section><section prefix="(7)">The cost-effectiveness of the Program versus the direct and indirect costs of the HIV infection in terms of medical treatment and other services normally required by HIV-infected individuals;</section><section prefix="(8)">The strengths and weaknesses of the Program; and</section><section prefix="(9)">The advisability of continuing the Program.</section></section>
    <section prefix="(c)">As part of its plans for data collection and Program evaluation described under subsections (a) and (b) of this section, the Baltimore City Health Department shall develop and implement a methodology:<section prefix="(1)">For identifying Program hypodermic needles and syringes, such as through the use of bar coding or any other method approved by the oversight committee; and</section><section prefix="(2)">To perform HIV antibody testing on the residue left in a sample of hypodermic needles and syringes returned to the Program.</section></section>
  </text>
</law>
